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The role of oligodendrocyte precursor cells expressing
the GPR17 receptor in brain remodeling after stroke
Elisabetta Bonfanti1,5, Paolo Gelosa2,5, Marta Fumagalli1, Leda Dimou3, Francesca Viganò3, Elena Tremoli2, Mauro Cimino4,5,
Luigi Sironi*,1,2,5 and Maria P Abbracchio1,5
Following stroke-induced neuronal damage, quiescent oligodendrocyte precursors (OPCs) are activated to proliferate and later to
differentiate to myelin-producing cells. GPR17, a receptor transiently expressed on early OPCs, has emerged as a target to
implement stroke repair through stimulation of OPC maturation. However, being GPR17 completely downregulated in myelin-
producing oligodendrocytes, its actual role in determining the final fate of OPCs after cerebral ischemia is still uncertain. Here, to
univocally define the spatiotemporal changes and final fate of GPR17-expressing OPCs, we induced ischemia by middle cerebral
artery occlusion (MCAo) in reporter GPR17iCreERT2:CAG-eGreen florescent protein (GFP) mice, in which, upon tamoxifen
treatment, cells expressing GPR17 become green and traceable for their entire life. Starting from 3 days and up to 2 weeks after
MCAo, GFP+ cells markedly accumulated in regions surrounding the ischemic lesion; several of them proliferated, as shown by
co-labeling of the DNA synthesis marker 5-Bromo-2′-deoxyuridine (BrdU). Almost all GFP+/BrdU+ cells expressed the OPC early
marker neural/glial antigen 2 (NG2), indicating that they were still precursors. Accumulation of GFP+ cells was also because of OPC
recruitment from surrounding areas, as suggested in vivo by acquisition of typical features of migrating OPCs, shown in vitro in
presence of the chemoattractant PDGF-AA and confirmed by transplantation of GFP+-OPCs in wild-type MCAo mice. Eight weeks
after MCAo, only some of these precociously recruited cells had undergone maturation as shown by NG2 loss and acquisition of
mature myelinating markers like GSTpi. A pool of recruited GFP+-OPCs was kept at a precursor stage to likely make it available for
further insults. Thus, very early after ischemia, GFP+-OPCs proliferate and migrate toward the lesion; however, most of these cells
remain undifferentiated, suggesting functional roles other than myelination.
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Neurological and neurodegenerative disorders are character-
ized by extensive loss of myelin sheath and defective
remyelination.1 In the central nervous system (CNS), myelin
is produced by oligodendrocytes, which originate from
oligodendrocyte precursors (OPCs) expressing the neural/
glial antigen 2 (NG2). The proliferation and differentiation of
OPCs are greatly increased after brain damage in the region
adjacent to the ischemic ‘core’, when they contribute to
remyelination.2 However, despite injury-induced OPC activa-
tion, damage also progresses at later phases after ischemia,
indicating that the capability of OPCs to maturate to new
myelinating oligodendrocytes is only partially successful.
Interestingly, the presence of recruited immature OPCs is
documented at the border of the lesion even at later times after
injury, suggesting that either their differentiation is blocked at
the pre-oligodendrocytes stage, or that these cells exert
additional roles besides differentiation to myelinating cells.
Recent data have highlighted the GPR17 receptor as a
potential target to implement repair and remyelination under
neurodegenerative conditions.3–5 GPR17 is already present in
early NG2+-OPCs, is induced in differentiating cells up to the
immature oligodendroglial stage, and is then progressively
downregulated to allow cells completing maturation.6,7
Interestingly, GPR17 expression is increased after trau-
matic brain injury in patients,8 after brain ischemia in mice4
and in several animal models of CNS injury.5,9–11 However, the
process underlying the accumulation of GPR17+ cells at the
site of ischemic lesions,4,12 the rate and kinetics of their
maturation and their final fate are still largely unknown.
Owing to the only transient expression of GPR17 that
completely disappears before cells reach terminal maturation,
it has been difficult to univocally follow in vivo the destiny
and role of GPR17-expressing OPCs. To solve this problem, in
this study we induced stroke by permanent middle
cerebral artery occlusion (MCAo) in GPR17iCreERT2:CAG-
eGreen florescent protein (GFP) transgenic mice, the first
fluorescent reporter mouse line for GPR17 fate-mapping
studies. In these mice, upon tamoxifen administration,
enhanced GFP is expressed in OPCs where the GPR17
promoter is active, without affecting the physiological
expression and function of the receptor. In this way, all cells
expressing GPR17 at the time of tamoxifen administration
(and their progeny) become fluorescent and can be
easily visualized by fluorescence microscopy throughout
their life.10
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Results
After MCAo, GFP+-OPCs are rapidly recruited to the
regions surrounding the ischemic lesion. Previous data
on rodents indicate that, at early times after MCAo, GPR17+-
OPCs start accumulating in the peri-lesion area, suggesting a
role of these cells in reparative/regenerative processes.10,13
However, no data on the fate of these cells at longer times
after MCAo are available. To shed light on this issue, we
induced MCAo in the conditional GPR17iCreERT2:
CAG-eGFP mouse line for fate-mapping studies10
(Supplementary Figure 1).
Figure 1a shows representative ipsilateral hemispheres
72 h, and 4 and 8 weeks after MCAo, immunostained with an
anti-GFP antibody. GFP+ cells start accumulating early in the
peri-infarcted area. With time, the ischemic area, as identified
by MRI, became smaller and, 8 weeks after MCAo, GFP+ cells
delimited this area. To detail this ischemia-induced cell
reaction, we analyzed four different regions of interest
(ROIs: dorsal cortex, ventral cortex, corpus callosum and
striatum) (Figure 1b). Two-way ANOVA analysis demonstrates
that both the ischemia and time factors significantly affected
the number of GFP+ cells, but there was no interaction
between these two parameters. Regarding the ischemia
factor, at early time points (i.e., within 2 weeks) a significant
increase in the number of GFP+ cells was observed in
ventral and dorsal cortex of the ipsilateral compared with the
contralateral side. At later time points (i.e., starting from
2 weeks), a significant increase in the number of GFP+ cells
was observed only in corpus callosum and striatum. These
different behaviors suggest a gradient in the detected
changes, which develop with a slower kinetic in ROIs
more distal from damage (Figures 1c and d). In
sham-operated animals, no differences in the number of
GFP+ cells in the ipsilateral compared with contralateral
sides were found (data not shown). We conclude that the
higher numbers of GFP+ cells in the ipsilateral side of
MCAo mice are specifically related to induction of brain
ischemia.
Regarding the time factor, an increase in GFP+ cells was
observed ‘per se’ in the contralateral uninjured sides of all
analyzed ROIs (Figures 1c and d), suggesting that the number
of cells increases with age. In the ischemic sides at later times
after MCAo, the number of GFP+ cells was significantly
increased compared with 72 h only in corpus callosum and
striatum (see legend of Figure 1d), suggesting different
kinetics in the development of ischemic consequences in the
different ROIs.
To further investigate these differences, we then performed
a Pearson and simple linear regression analysis (Figure 2).
Data confirmed a positive correlation between the number of
GFP+ cells and time from surgery in all contralateral uninjured
ROIs, whereas in the ipsilateral ischemic sides this correlation
was present only for striatum and corpus callosum
(Supplementary Table 1). The lack of a linear correlation with
time for ventral and dorsal cortex suggests that, in regions
closer to damage, tissue remodeling is more complex and
cannot be simply described by a linear equation. Data also
suggest that, in these ROIs, changes are likely to have already
occurred by 72 h.
After MCAo, GFP+-OPCs are rapidly polarized toward the
lesion and then undergo morphological changes. Close
to ischemic damage, OPCs have been reported to assume
Figure 1 GFP+ cells are recruited in regions surrounding the ischemic lesion. (a) Representative image of GFP immunofluorescence in ischemic brain slices from
GPR17iCreERT2:CAG-eGFP mice 72 h, 4 and 8 weeks after MCAo. Representative T2W brain images of the same mouse at the same slice level for each time point. At 72 h, the
dashed line delimitates the vasogenic edema, which is not visible at 4 weeks after MCAo (the dashed line delimitates the atrophic damage). Arrow indicates the elongation of
corpus callosum and the cortical atrophy at 8 weeks after MCAo. (b) Drawing showing the ischemic lesion (dashed area) and the sampled fields in the selected ROIs: dorsal
cortex (blue), ventral cortex (green), corpus callosum, cc (yellow) and corpus striatum (purple). (c) Representative images of GFP+ cells (green) and HOECHST 33258 (blue) in
contralateral and ipsilateral dorsal cortex over time. Scale bar= 20 μm. (d) Bar graphs of the quantitative analysis of the number of GFP+ cells in the selected ROIs of both
hemispheres (n= 3 mice for 1 week and 4 weeks; n= 4 mice for 72 h and 2 weeks; n= 5 mice for 8 weeks). Two-way ANOVA analysis demonstrates that both the ischemia
(Po0.001) and time (Po0.05 for ventral cortex, Po0.01 for dorsal cortex and Po0.001 for corpus callosum and striatum) significantly affected the number of GFP+ cells. The
effect of ischemia is reported in the small tables below each graph: *Po0.05, **Po0.01, ipsilateral versus contralateral side; Bonferroni post-hoc analysis. The effect of time is
reported on each graph: *Po0.05, **Po0.01, ***Po0.001 versus 72 h; #Po0.05, ##Po0.01, ###Po0.001 versus 1 week; $Po0.05, $$Po0.01, versus 2 weeks; Bonferroni
post-hoc analysis
Figure 2 Correlation between the increase of GFP+ cells and days from the MCAo in the contralateral and ipsilateral ROIs. Scatter plot representation of the positive
correlation between days from MCAo (x axis) and number of GFP+ cells (y axis) in different ROIs
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monopolar/bipolar shape with elongated processes,14 which
have been interpreted as a prerequisite for their migration.15
To investigate whether MCAo modifies the morphology of
GFP+ cells, we performed a Sholl and Skeleton analysis in
dorsal cortex regions at 72 h, 1 and 2 weeks after MCAo
(Figures 3c–e).
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At 72 h, in ipsilateral side, GFP+ cells showed a simpler
morphology with fewer and more elongated processes polar-
ized to the lesion, to suggest that these cells are attracted to the
damaged area (Figures 3b and f). Indeed, ischemia induced an
early change of the Sholl plot profile, a reduction of the critical
value, a decrease of the number of branches, process
endpoints and junctions, and an increase of branch length
parameters (Figures 3g–i). On the contrary, 1 and 2 weeks,
morphological parameters did not show any significant
difference, suggesting that the morphological changes of
GFP+ cells mainly occur at early times (Figures 3g–i).
To investigate whether the morphology of GFP+ cells was
influenced by ischemia-induced maturation of OPCs, we
analyzed separately the GFP+/NG2+ and GFP+/NG2− cells
(representing, respectively, early or more mature OPCs). We
found that the morphological changes observed in GFP+ cells
in ipsilateral side at 72 h, were restricted to the GFP+/NG2+
cellular sub-population. A detail description of the results is
reported in Supplementary Figure 2.
Globally, these results indicate that ischemia induces
phenotype- and time-dependent changes in themorphological
structure of GFP+ cells.
The migratory capacity of GFP+-OPCs is markedly
increased after MCAo. To assess whether the ischemia-
induced morphological changes of GFP+-OPCs are indeed
associated with altered migratory abilities, we performed an
in vitro cell migration assay. For these experiments, we used
OPCs isolated from neonatal GPR17iCreERT2:CAG-eGFP
fluorescent mice containing both GFP+ and GFP− cells. The
vast majority of these GFP+ and GFP− cells expressed both
NG2 (90.89± 4.48% and 83.86± 5.29%, respectively;
Figure 4a) and GPR17 (91.28±8.67% and 76.85±8.71%,
respectively; Figure 4b). In the presence of PDGF-AA, a
known chemoattractant factor accumulating at ischemic
lesions, both GFP+ and GFP−-OPCs showed significantly
increased motility (33.42± 7.09% and 51.0± 8.67%, respec-
tively) compared with unstimulated cells (Figure 4c), to
confirm that, in a similar way to normal OPCs, recombinant
GFP+-OPCs are sensitive to chemoattractant signals.16
To evaluate whether the presence of NG2 modifies GFP+
cell migratory capacity, we better characterized the GFP+
migrated cell population. No differences in the percentage of
NG2+ cells within GFP+ migrated cells were found either in the
presence or in the absence of PDGF-AA. Moreover, we
observed no significant changes in the percentage of NG2+
and NG2− cells in the GFP+ cell populations before (Figure 4a)
and after (Figure 4d) migration. Taken together, these data
suggest that the presence of NG2 does not confer additional
migratory capacities to the specific subcellular population of
OPCs expressing GPR17 (Figure 4d).
To detail the migratory abilities of OPCs in vivo after MCAo,
we transplanted fluorescent GFP+-OPCs in wild-type mice
(Figure 4e). At the time of the graft, almost all fluorescent
transplanted cells did express GPR17 (Figure 4b and above).
One week after the graft, many GFP+-OPCs had moved away
from the site of injection of a distance up to 900 μm in MCAo
mice showing greater migratory abilities compared with sham-
operated mice (Figure 4f).
Then, to investigate whether the presence of GPR17
confers different abilities to the transplanted cells, we
quantified the percentage of GFP+ cells expressing or not
expressing GPR17 1 week after the injection. In sham-
operated mice, the percentage of all the transplanted GFP+
cells that still maintainedGPR17was significantly lower (about
30%) compared with the cells that had lost the receptor
(Figure 4g), suggesting progression to more differentiated
stages. Instead, in MCAo mice, the percentage of cells
maintaining GPR17 was about the 50% of total GFP+ cells
(Figure 4g).
Altogether, these data demonstrate that the ischemic
environment modifies the mobility of GFP+-OPCs, recruiting
them from the parenchyma to the areas surrounding the lesion
and likely inducing the release of factors maintaining GPR17
expression and thus preserving GFP+ cells at a precursor
stage. We also speculate that the presence of GPR17 favors
OPCmigration, as shown by the increased number of GPR17+
cells at greater distances from the injection side in MCAo
compared with sham-operated mice.
After MCAo, GFP+-OPCs are also rapidly induced to
proliferate. To understand whether the MCAo-induced
increase in the number of GFP+ cells could be because of
a higher proliferation rate, we treated animals with 5-Bromo-
2′-deoxyuridine (BrdU) (Supplementary Figure 1). We found
that, in ipsilateral regions, the number of GFP+/BrdU+ cells
increased with time (Figures 5a and b). Of note, not all GFP+
cells colocalized with BrdU, suggesting the presence of a
sub-population of GFP+ cells that are more prone to
proliferate after MCAo. As expected from previous data
suggesting that OPCs do slowly, but significantly, proliferate
under physiological conditions,17 an age-dependent increase
in the number of proliferating GFP+ cells was also found in the
unlesioned side (i.e., dorsal cortex: Po0.05, striatum:
Po0.05; Figure 5b) and in sham-operated animals. However,
in the latter, no statistically significant differences were
Figure 3 GFP+ cells undergo morphological changes in response to brain ischemia. (a and b) Representative images of GFP immunofluorescence of contralateral (a) and
ipsilateral (b) hemispheres from GPR17iCreERT2:CAG-eGFP mice 72 h after MCAo. Insets show higher magnification of representative non polarized GFP+ cells with cell
processes extending in all directions (contralateral side, a) or highly ‘polarized’ GFP+ cells showing a bipolar shape, with processes aligned with the cell body and extended toward
the ischemic area (ipsilateral ischemic side in b; dotted line indicates the borders of the ischemic core). (c) Representative images of a GFP+ (green) and NG2+ (red) selected for
the morphological analysis. Scale bar= 20 μm. (d) Illustration of Sholl analysis used to quantify process branching. The number of intersections made by the extending
processes with each circle was automatic counted and used as a measure of process branching. (e) Illustration of skeletonized cells; Skeleton analysis was used to get
information on the cell morphology complexity. (f) Representative images of GFP+ cells (green) and HOECHST 33258 (blue) in contralateral and ipsilateral dorsal cortex at 72 h,
1 week and 2 weeks after MCAo. High magnification of images at 72 h is reported. Scale bar= 20 μm. (g) Sholl analysis plot of GFP+ cells and (h) bar graphs of Critical value,
Critical radius and Ramification index at 72 h, 1 week and 2 weeks after MCAo. (i) Skeleton analysis data summary. *Po0.05; **Po0.01; ***Po0.001; Student’s t-test
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Figure 4 The migration capacity of GFP+ cells is influenced by brain ischemia. (a and b) Stacked bar graphs show the quantitative analysis of percentages of NG2+ and
NG2− cells (a) and of GPR17+ and GPR17− cells (b) both within the GFP+ and GFP− cell population (n= 3 coverslips from three independent OPC preparations). (c) Bar graphs
show the results of the quantitative analysis of cell migration assay performed in three independent experiments of GFP+ and GFP− cells. Changes in number of migrated GFP+
cells were related to control condition set to 100%. **Po0.01; Mann–Whitney analysis. (d) Stacked bar graphs show the results of the quantitative analysis of percentages of
NG2+ and NG2− cells within the migrated GFP+ cell population (n= 3 independent experiments). (e) Representative image of GFP immunohistochemistry of an ischemic wild-
type mouse at 7 days after the injection. The concentric circles represent the distances from the injection site, starting from 150 μm. In the insert is reported the T2W image of
brain coronal section of the same mouse acquired 24 h after MCAo and before the injection of GFP+ OPCs. The red arrow represents the injection track. (f) The bar graph shows
the quantification of the percentage of GFP+ cells, which have migrated at different distances from the injection site (n= 2 sham-operated mice; n= 3 MCAo mice). *Po0.05;
**Po0.01; two-way ANOVA followed by Bonferroni post-hoc analysis. (g) The bar graph shows the quantification of the percentage of GFP+/GPR17+ and GFP+/GPR17− cells,
which have migrated at different distances from the injection site (n= 2 sham-operated mice; n= 3 MCAo mice). *Po0.05; **Po0.01; two-way ANOVA followed by Bonferroni
post-hoc analysis
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detected between the ipsi- and contralateral sides at any of
the analyzed time points (data not shown). Globally, these
results show that, at least in part, the increased number of
GFP+ cells can be ascribed to ischemia-induced higher
proliferation rate.
The final fate of the GFP+ cells is altered by brain
ischemia. To better characterize the phenotypic changes of
the GFP+ cells pool during the post-ischemic period, we
performed a fate-mapping analysis with stage-specific
oligodendrocyte markers (NG2 for early OPCs, GPR17 for
immature oligodendrocytes and GSTpi for mature
oligodendrocytes).
As a first step, to get more information on the early
proliferating GFP+/BrdU+ cells, we performed triple immunos-
tainings with GFP, NG2 and BrdU antibodies (Figure 6a). At
72 h, almost all GFP+/BrdU+ cells still expressed NG2,
indicating that during the acute reaction to injury all the
proliferating recombined cells still remain at a precursor stage.
Interestingly, already at 1 week, a percentage of these cells no
longer expressed NG2. However, the loss of NG2 positivity
reached statistical significance only at 8 weeks (i.e., Po0.05
in ventral cortex, corpus callosum and striatum; Figure 6b). In
the contralateral side, negligible changes were observed
(Figure 6b).
Our conclusion is that, after MCAo, GFP+ cells are initially
induced to move toward the lesion while increasing their
proliferation rate and that, subsequently, a subset of these
cells is undergoing differentiation.
At 72 h, the number of GFP+/NG2+ cells was increased in
the ipsilateral side in a different way according to the brain
region, reaching statistical significance in dorsal cortex
(Po0.05) (Figures 7a and b). This increase was still present
at 2 weeks and then disappeared (Figure 8b), indicating that,
after a very early recruitment of the NG2+/GFP+ cells, a pool of
this OPC sub-population is preserved and does not undergo
any further changes, to likely avoid exhaustion of brain’s repair
abilities; conversely, a second pool of these recruited cells is
addressed to maturation to sustain lesion repair.
Regarding this second pool of GFP+ cells, to discriminate
cells at intermediate stages frommoremature phenotypes, we
analyzed in detail the following cell subpopulations: GFP+/
GPR17+, GFP+/NG2−/GSTpi− and GFP+/GSTpi+ cells. In line
with our hypothesis, after MCAo, although less numerous
compared with GFP+/NG2+ cells, GFP+/NG2− cells initially
expanded only in the ROIs closer to damage (Po0.05 in
ventral cortex at 72 h); then, starting from 2weeks, the number
of GFP+/NG2−/GSTpi− cells also significantly increased in
corpus callosum and striatum, suggesting that ischemia is
speeding up their maturation (Figures 7b and 8b). Moreover, in
ventral cortex and striatum, a slight increase in GFP+/GPR17+
cells was observed at 8 weeks (Supplementary Figure 3).
Globally, these data indicate that ischemia induces maturation
of GFP+ cells.
As brain injury resulting in demyelination can induce adult
OPCs to reacquire some stemcellness,18 we also tested the
hypothesis that the GFP+/NG2− sub-population of cells in the
MCAo brain is not actually composed of more mature
precursors, but indeed represent a new ischemia-induced
population of cells reverting to more immature stages. We
found that, up to 8 weeks after MCAo, no GFP+ cells
expressed the stem cell marker GFAP (data not shown),
suggesting that there is not a complete reversal to a stem cell
stage. However, our data support recent results suggesting
reversion to neonatal-like immature states of CNS progenitors
characterized by migratory activity.19
Finally, quantitative analysis demonstrated that the number
of GFP+/GSTpi+ cells slightly increased in all the considered
regions, reaching a statistically significance at 8 weeks in
striatum (Po0.05) (Figures 7b and 8a).
Discussion
Not only neurons but also oligodendrocytes are severely
affected by brain ischemia20,21 and the loss of these cells
causes myelin damage, contributing to stroke-associated
deficits. Of note, the recovery of neurological function after
stroke increases in parallel with white matter reorganization in
rodents22 and microstructural integrity of white matter tracts is
correlated with residual motor output in stroke patients.23
Thus, understanding the long-term behavior of OPCs, the
myelin-producing cells, after stroke is crucial to find new
strategies to promote endogenous remyelination and
functional recovery.24
In this study, we have addressed this issue by using the
GPR17iCreERT2:CAG-eGFP mice that allows to trace the
proliferation, migratory abilities, differentiation and final fate of
GPR17-expressing OPCs. As GPR17 is only transiently
expressed by these precursors and completely disappears
before they reach terminal maturation, these mice represent
the only tool to follow the destiny of cells that have
expressed GPR17.
We previously showed that, in this transgenic mouse line,
GPR17+-OPCs (i.e., GFP+ cells) are reluctant to differentiate
under healthy conditions, but can rapidly respond to injury,
suggesting they may represent a ‘reserve pool’ of adult
progenitors maintained for repair purposes.10 Here, we
provide the first comprehensive in vivo fate-mapping analysis
of these cells in a model of permanent brain ischemia up to
8 weeks.
In line with our previous results,4,12 72 h after MCAo,
GPR17+ cells accumulate in the regions surrounding the
lesions, and most of them still expressed the early OPC
marker NG2. The increase of GFP+ cells persisted for at least
8 weeks with different regional kinetics that was faster in ROIs
closer to the lesion. Highly relevant, a similar spatiotemporal
gradient of the presence and activation of these cells has also
been found in patients after traumatic brain injury.8
Our data show that the increased number of GFP+ cells
around the ischemic lesion is, at least in part, because of
ischemia-induced proliferation. The analysis of the number of
GFP+ cells over time revealed that the increase of GFP+ cells
mainly occurred in the early phases after MCAo. At later times,
the rate of increase of these cells in the ipsilateral regions
became similar to that observed in the contralateral ones,
indicating a reduction with time of the ischemia-mediated
effect. The proliferation rate of GFP+ cells indeed reached its
maximum during the first week after MCAo, indicating that this
pool of cells is extremely reactive to injury. Interestingly, some
proliferating GFP+ cells were detected in the unlesioned side,
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Figure 5 Brain ischemia induces proliferation of GFP+ cells. (a) Representative images of GFP (green) and BrdU (red) immunofluorescence in contralateral and ipsilateral
dorsal cortex of mice 72 h and 8 weeks after MCAo. Arrows show double-positive cells. Scale bar= 20 μm. (b) Bar graphs showing the quantitative analysis of the number of
BrdU+-GFP+ cells (n= 3 mice for 1 week; n= 4 mice for 72 h and 2 weeks; n= 5 mice for 8 weeks). *Po0.05, **Po0.01, ***Po0.001 ipsilateral versus contralateral side;
Student t-test. In contralateral dorsal cortex and striatum 2 weeks versus 72 h *Po0.05; one-way ANOVA followed by Bonferroni post-hoc analysis
Fate mapping of GPR17 cells after stroke
E Bonfanti et al
8
Cell Death and Disease
and, consistent with previous data,10 a slower and more
moderate increase of GFP+ cells was observed in sham-
operated mice. This confirms that under physiological condi-
tions, OPCs slowly but steadily proliferate throughout life.
Moreover, our data indicate that, besides proliferation, the
increase of GFP+ cells is because of recruitment of migrating
GFP+-OPCs toward the ischemic area. In this respect, GFP+-
OPCs underwent early morphological changes, acquiring a
simpler structure that can be also interpreted as an augmen-
ted migratory capacity. Specifically, 72 h after MCAo, the
cellular complexity of GFP+/NG2+ cells significantly
decreased in the ipsilateral side, and these cells exhibited
fewer and more elongated processes in the direction of the
lesion. Based on previous data showing that motile OPCs lose
their un-oriented radial morphology and extend processes in
the direction of migration15 and through the lesion,25 we
conclude that the GFP+/NG2+ cells are indeed migrating
toward the lesion. This conclusion is supported by our in vitro
results, and by the increased migratory abilities of GFP+ cells
when transplanted in MCAo mice.
These results are in line with our previous data demonstrat-
ing that GPR17 promotes OPCs migration in vitro16 and are
consistent with literature results. Bipolar morphology was
required for directional migration of OPCs in vitro, whereas
increased number of cellular processes correlated with
random and slow migration.26 In living brain slices, motile
OPCs acquired a simple morphology whereas non-motile
cells showed a complex morphology.15 These motile cells
exhibited the same morphology described for OPCs moving
from sites of proliferation to sites of injury after carotid
ligation.27 As OPCs represent the majority of proliferating
cells in the healthy adult brain,17 we do not rule out that some
of the migrating GFP+/NG2+ cells may be newborn cells
generated from the originally green-labeled GPR17+ cells.
The detected morphological changes weakened at later
post-ischemia phases, when activated GFP+/NG2+ cells
started maturating to myelinating phenotypes. In previous
studies in healthy and stab wound injured brain, post-mitotic
GPR17+ cells acquired a pre-myelinating phenotype. How-
ever, the exact relationship between proliferation and progres-
sion to mature oligodendrocytes remained uncertain,5,28 and
whether and how ischemia influenced the fate of these cells
was unknown. The present data clearly show that, only
starting from 2 weeks and to a greater extent 8 weeks after
MCAo, GFP+-proliferating cells loseNG2 positivity, suggesting
lineage progression to more advanced stages and terminal
differentiation.
As OPCs of the gray and white matter are known to behave
in different ways,29 to evaluate whether, depending on the
extracellular microenvironment, the localization of the reacting
GFP+ cells influences their differentiation properties, we
detailed their behavior in either gray and white matter regions.
Results indicate that the early recruitment of the GFP+/NG2+
cells in the regions surrounding the lesion was exclusively
related to their proximity to the ischemic area.
The role of the expanded GFP+/NG2+ cells pool in the early
phases after MCAo remains unclear. These cells may
proliferate to assure that a sufficient number of cells under-
goes myelination, and/or to assume completely different roles
implementing brain repair. In this respect, it has been
hypothesized that, beyond myelination, OPCs may also have
trophic functions.30 OPCs indeed express high levels of active
factors and cytokines regulating crucial biological processes
like proliferation, differentiation and cell survival. In hippocam-
pal slices undergoing oxygen glucose deprivation, release of
BDNF and IL-10 by co-cultured OPCs improves cell survival
and proliferation.30 The trophic effect of oligodendrocytes is
not only restricted to OPCs but also extends to myelin, which
sustains axonal homeostasis and neuronal survival.31 Trans-
planted human embryonic stem cells derived OPCs decrease
infiltrating inflammatory cells within the subarachnoid space32
likely through increases of CCL2, CXCL10, sICAM-1 and
TIMP-1, which, may, in turn, affect the migration of inflamma-
tory cells.32 Another possible role of the increased GFP+/
NG2+-pool could be to preserve the physical compartmenta-
tion of the brain. OPCs increase brain–blood barrier tightness
via TGF-β signaling33 and may be also involved in scar
formation. NG2-glia, together with microglia, are the first cells
to react and strongly accumulate around the injury34,35 and
could be responsible for scar formation by building a high cell
density area,36 as we also observed starting from 4 weeks
after MCAo.
Notably, at later times after MCAo, the number of GFP+/
NG2+ cells in the ipsilateral is similar to that of the contralateral
side, indicating that, after ischemia-induced early activation,
the pool of GFP+/NG2+ cells is restored to basal levels.
Similarly, after brain stab wound, the number of NG2+ cells
progressively decreases over time, leading to restoration of
their physiological density.10 Globally, these data confirm that
the adult brain does have the capacity to preserve the
homeostasis of the OPC pool also in case of initial loss of
oligodendrocytes, as observed in cerebral hypoperfusion.37,38
Of note, the number of GFP+/NG2-/GSTpi− cells, which
likely are the pre-oligodendrocytes, is increased at 2 weeks
after MCAo, suggesting that the initial activation of these cells
is not finalized to promoting a rapid differentiation to myelinat-
ing phenotypes. In fact, the increase of percentage of GFP+
cells expressing GSTpi that reached a statistical significance
only at later phases after MCAo.
In summary, this study characterizes the behavior and fate
of GPR17-expressing OPCs in the ischemic brain over time.
Results indicate that ischemia induces, sequentially: (i) early
morphological changes of GPR17+ cells consistent with their
migration toward the injury; (ii) a rapid proliferative response of
GFP+ cells; (iii) a later increase of recombinant cells at
intermediate stages of maturation; (iv) the subsequent
progression of some of these cells to myelinating phenotypes.
Of interest, GPR17+ cells undergo maturation with different
kinetics in the selected ROIs, depending upon their distance
from the ischemic core, suggesting the existence of a gradient
of factors that are released by the core area and act as
differentiating agents, as nevertheless already suggested for
GPR17+-OPCs in patients after traumatic brain injury.8 More-
over, the very early activation of these cells suggests that the
role of OPCs goes well beyond myelination, indicating further
un-explored trophic roles. The pharmacological manipulation
of GPR17 will help establishing the ability of these cells to
eventually sustain myelination and to improve the functional
recovery of the regions surrounding the ischemic lesion.
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Materials and Methods
Animals and experimental procedures. The procedures concerning
animal care, surgery, killing were performed in accordance with national (D.L. n.26,
2014) and International laws and policies (EU Directive 2010/63/EU) and approved
and authorized by the National Ministry of Health-University of Milan Committee
(approval number 12/12-30012012 and 479/2015-PR). The protocol used is also in
accordance with ARRIVE guidelines.
Eleven weeks old GPR17iCreERT2:CAG-eGFP report mice received 10 mg
tamoxifen (Sigma-Aldrich, Taufkirchen, Germany), dissolved in 10% ethanol and 90%
corn oil, three times by gavage once every second day. After 3 weeks of wash-out
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from tamoxifen, the mice were anesthetized with ketamine (80 mg/kg) and
xylazine (16 mg/kg) and underwent permanent MCAo.39 Starting from 1 day
before surgery, mice received 1 mg/ml BrdU (Sigma-Aldrich) in drinking water
supplemented with 2% sucrose for 15 days. Mice were killed at 72 h and 1, 2, 4
and 8 weeks after MCAo (n= 3–5 mice for each time point) (see Supplementary
Figure 1). In parallel, sham-operated mice were included in each experimental
group.
Brain damage visualization. MRI investigations were performed in mice
anesthetized with 1% isofluorane in 1l/min of O2 at 72 h and 1, 2, 4 and 8 weeks
after ischemic insult using a 4.7 T, vertical super wide bore magnet of a Bruker
Avance II spectrometer with micro imaging accessory (Ettlingen, Germany). Brain
damage was visualized by means of T2-weighted MR imaging using a RARE
sequence.39
Immunofluorescence analysis. Mice were perfused with phosphate-
buffered-saline and then 4% paraformaldehyde in phosphate-buffered-saline for at
least 25 min. Brains were removed, post-fixed 1 h in the same solution and
cryoprotected in 30% sucrose solution until precipitation at 4 °C. Coronal sections of
20-μm were incubated with the following primary antibodies: chicken anti-GFP
antibody (1:1400; Aves Labs, Inc., Tigard, OR, USA), rat anti-BrdU (1:150; Abcam,
Cambridge, UK), rabbit anti-GSTpi (1:500; MBL, Woburn, MA, USA), rabbit anti-
NG2 (1:2000; Millipore, Temecula, USA), rabbit anti-GFAP (1:300; Dako, Glostrup,
Denmark) and rabbit anti-GPR17 (1:20 000; home-made antibody kind gift by P
Rosa). Incubation with primary antibodies was made overnight at 4 °C in PBS with
1% normal goat serum (Dako) and 0.1% Triton-X 100, whereas for anti-NG2 in PBS
with 1% normal goat serum and 0.3% Triton-X 100. The sections were exposed for
2 h at room temperature to secondary antibodies (Life Technologies, Monza, Italy).
For rabbit anti-NG2 and GPR17, the signal intensity was enhanced using the High
Sensitivity Tyramide-Rhodaminate Signal Amplification kit (Perkin-Elmer, Monza,
Italy) following the manufacturer’s instructions. For triple GFP/NG2/BrdU labeling,
staining of BrdU was performed last, after fixing sections with 4% paraformaldehyde
for 10 min and incubating them with HCl 2N for 45 min at 37 °C. Nuclei were labeled
with Hoechst 33258 (0.3 μg/ml; Life Technologies).
Figure 7 Early phase after MCAo, GFP+ cells mainly express the NG2 antigen. (a) Representative images of GFP (green) and NG2 (red) immunofluorescence in
contralateral and ipsilateral dorsal cortex of mice 72 h and 1 weeks after MCAo. Arrows show GFP+/NG2+ cells. Scale bar= 20 μm. (b) Stacked bar graphs show the quantitative
analysis of the number of GFP+/NG2+ cells (n= 4 mice 72 h; n= 3 mice for 1 week). *Po0.05 ipsilateral versus contralateral side; Student's t-test
Figure 6 The fate of the GFP+/BrdU+ cells is altered by brain ischemia. (a) Representative images of GFP (green), BrdU (white) and NG2 (red) immunofluorescence in
contralateral and ipsilateral dorsal cortex of mice 72 h and 8 weeks after MCAo. Arrows (yellow) show GFP+/BrdU+ cells positive for NG2 whereas head arrows (blue) show GFP+/
BrdU+ cells negative for NG2. Scale bar= 20 μm. (b) Stacked bar graphs show the quantitative analysis of percentages of NG2+ and NG2− cells within the GFP+/BrdU+ cell
population in contralateral and ipsilateral ROIs (n= 3 mice for 1 week and 8 weeks; n= 4 mice for 72 h and 2 weeks) in the contralateral (upper graphs) and ipsilateral (lower
graphs) side. NG2+ cells in contralateral ventral cortex: 8w versus 72 h *Po0.05; NG2+ cells in ipsilateral ventral cortex and corpus callosum: 8 weeks versus 72 h *Po0.05;
NG2− cells in ipsilateral corpus callosum and striatum: 8 weeks versus 72 h *Po0.05; one-way ANOVA followed by Bonferroni post-hoc analysis. NG2+ and NG2− cells in
ipsilateral striatum: *Po0.05; one-way ANOVA
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ROI selection and cell counts. The number of GFP-positive, double-
positive GFP/BrdU, GFP/NG2, GFP/GPR17, GFP/GSTpi and triple-positive GFP/
BrdU/NG2 was quantified, by a blinded investigator, on two slices per mouse from
− 1.00 to 0.00 mm from bregma.40 For the quantitative analysis, four anatomically
defined ROIs surrounding the ischemic lesion, and their respective mirror ROIs in
the contralateral side, were identified (ventral and dorsal cortex, corpus callosum
and striatum). Briefly, after identifying the boundaries of the ischemic lesion we
selected specific fields (281.25 × 281.25 μm) for cell count as illustrated in the
drawing (Figure 1b). Images were acquired at × 40 magnification using a confocal
microscope (merge of 8-μm z-stack at 2-μm intervals; LSM510 META, Zeiss,
Oberkochen, Germany).
Sholl and skeleton analysis. A Sholl analysis method was developed to
quantify GFP+, GFP+/NG2+ and GFP+/NG2− cell morphology in immunofluorescent
images of brain at 72 h, 1 and 2 weeks after MCAo. This morphological analysis
was performed only with well-identified or isolated GFP+ cells, and on at least 18
cells for hemisphere of each mouse. Confocal images were acquired at each
ipsilateral and contralateral dorsal cortex as detailed in drawing image (Figure 1b).
The local contrast of GFP channel was enhanced and a basic grayscale
morphologic erosion was performed to optimize the visualization of cellular
processes. The resulting images were converted to a binary signal and analyzed
using Simple Neurite Tracer plugin of the Fiji software, ImageJ(https://imagej.net/Fiji/
Downloads). Cellular branches were manually traced and the center for the Sholl
Figure 8 Late phase after MCAo, GFP+ cells progressively lose the NG2 antigen and start expressing the mature oligodendrocyte marker GSTpi. (a) Representative images
of GFP (green) and GSTpi (red) immunofluorescence in contralateral and ipsilateral dorsal cortex of mice 2, 4 and 8 weeks after MCAo. Arrows show GFP+/GSTpi+ cells. Scale
bar= 20 μm. (b) Stacked bar graphs show the quantitative analysis of the number of GFP+/NG2+ cells, GFP+/NG2−/GSTpi− cells and GFP+/GSTpi+ cells (n= 4 mice 2 weeks;
n= 3 mice for 4 weeks; n= 5 mice for 8 weeks). *Po0.05, **Po0.01, ***Po0.001 ipsilateral versus contralateral side; Student's t-test
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analysis was pointed at the centroid of the nucleus. Concentric circles were
automatically drawn beginning at 2 μm from the center and increasing 2 μm with
every circle.
The Sholl analysis plugin was then applied to all traced cells to collect data on the
number of intersections between branches and each increasing circle to create a
Sholl plot. For each mouse, a mean Sholl plot was generated. The parameters used
for statistical analysis were: critical radius, critical value and ramification index.
The skeleton analysis plugin was applied in the same way and the parameters
used for statistical analysis were: number of branches, number of branch endpoints
and number of junctions, average and maximum branch length, and maximum
primary branch length.
OPC cultures. P0-P1 mice pups were subcutaneously injected with 30 ng
tamoxifen to induce recombination and killed after 3 days. Cortices were removed,
mechanically and enzymatically dissociated, suspended in Dulbecco’s modified
Eagle's medium containing 10% fetal bovine serum, 4 mM L-glutamine, 1 mM Na-
pyruvate, 100 U/ml penicillin, 100 U/ml streptomycin (all products from EuroClone,
Milano, Italy), and plated in poly-L-lysin-coated 60 mm dishes (3 × 106 cells). After
8 days, OPCs growing on top of a confluent monolayer of astrocytes were manually
detached. Contaminating microglial cells were eliminated by plating detached cells on
culture dishes for 1 h. OPCs were, then, collected and plated onto poly-DL-ornithine-
coated dishes (Sigma-Aldrich) in Neurobasal medium (Life Technologies) containing
2% B27, 4 mM L-glutamine, 100 U/ml penicillin, 100 U/ml streptomycin, 10 ng/ ml
platelet derived growth factor (PDGF-AA; Sigma-Aldrich) and 10 ng/ml basic fibroblast
growth factor (bFGF; Space Import Export, Milan, Italy) to promote cell proliferation.
After 2–3 days, cells were detached with accutase (Millipore) and used for migration
assay or directly injected in wild-type mouse brain. Immunocytochemistry for GPR17
and NG2 was done to characterize the isolated OPCs.3
Cell migration assay. Migration of GFP+-OPCs was performed with Boyden
chambers (8 μm pore size filter; Constar, Corning, NY, USA) as previously
described.16 Briefly, the chamber was nested inside the well of 24-well plates and
5 × 104 OPCs were seeded in the top of each insert with 200 μl of neurobasal
medium. The bottom well was filled with 600 μl of medium containing the
chemoattractant PDGF-AA (50 ng/ml). After 17 h, non-migrated cells were removed
from the top compartment with a cotton swab, whereas cells that had migrated to the
lower side of the filter were fixed with 4% paraformaldehyde and stained with Hoechst
33258, anti-GFP and anti-NG2 antibodies (see above). Images were acquired at × 20
magnification under an inverted fluorescence microscope (200M; Zeiss, Oberkochen,
Germany) and cells counted using the Image J software (US National Institutes of
Health, Bethesda, Marylan, USA). Data are expressed as a percentage of basal
migration, that is, the migration of OPCs without chemoattractant.
OPCs in vivo transplantation in MCAomice. Wild-type mice (C57Bl/6J,
2- to 3-month old) underwent MCAo as described above. As a control, sham-
operated mice were used. For cell transplantation, we followed a protocol previously
described.29 One day after MCAo, 1 μl of cell suspension (90 000 OPCs, see
above) was injected in the ipsilateral striatum using a Hamilton syringe (Hamilton,
75 SN 5 μl, Bonaduz, Switzerland). Coordinates of the site of injection were chosen
based on the lesion area visualized by MRI (approximately +0.2 mm anterio-
posterior, − 2.0 mm medio-lateral, − 3.0 mm dorso-ventral relative to the bregma).
Mice were killed 1 week post-transplantation and the brains collected as described
above. For each brain, we quantified the number of GFP+, GFP+-GPR17+ and
GFP+-GPR17− cells, which migrated from the injection site up to41800 μm in the
surrounding tissue, and then calculated the percentage of moving cells. Cells
remaining in the needle injection groove were not counted. We analyzed at least
three slides for each mice and 2–3 animals per condition.
Statistical analysis. The effect of time and ischemia on the number of GFP+
cells was evaluated by two-way ANOVA analysis followed by Bonferroni post-hoc
analysis. The effect of time on proliferated GFP+ cells was evaluated by one-way
ANOVA analysis followed by Bonferroni post-hoc analysis. The significance of the
between-group differences was computed by means of unpaired Student’s t-test
(ipsilateral versus contralateral side). Two-way ANOVA and Mann–Whitney analysis
were used to detect statistical significance in migration assay. Pearson correlation
test was used to evaluate the correlation between the number of GFP+ cells and the
days from the surgery. Simple linear regression analysis was used to test whether
the slopes and intercepts of the equation of a straight line obtained for contralateral
and ipsilateral side were significantly different for each ROI. Data are expressed as
mean±S.E.
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